Other Information
−Removed: Articles of Incorporation, filed as an exhibit to the Registration Statement on Form S-1, filed with the Securities and Exchange Commission (the “Commission”) on April 9, 2008 and incorporated herein by reference.
+Added: Form of Securities Purchase Agreement between Tonix Pharmaceuticals Holding Corp.
+Added: and the investors thereto, dated June 22, 2022, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 22, 2022 and incorporated herein by reference.
+Added: Form of Registration Rights Agreement between Tonix Pharmaceuticals Holding Corp.
+Added: and the investors thereto, dated June 22, 2022, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 22, 2022 and incorporated herein by reference.
+Added: Form of Side Letter between Tonix Pharmaceuticals Holding Corp.
+Added: and each investor, dated June 22, 2022, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 22, 2022 and incorporated herein by reference.
+Added: Articles of Incorporation, filed as an exhibit to the Registration
+Added: Statement on Form S-1, filed with the Securities and Exchange Commission (the “Commission”) on April 9, 2008 and incorporated
+Added: herein by reference.
Articles of Merger between Tamandare Explorations Inc.
−Removed: and Tonix Pharmaceuticals Holding Corp., effective October 11, 2011, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on October 17, 2011 and incorporated herein by reference.
−Removed: Third Amended and Restated Bylaws, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 3, 2016 and incorporated herein by reference.
−Removed: Certificate of Change of Tonix Pharmaceuticals Holding Corp., dated March 13, 2017 and effective March 17, 2017, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on March 16, 2017 and incorporated herein by reference.
−Removed: Certificate of Amendment to Articles of Incorporation, effective June 16, 2017, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 16, 2017 and incorporated herein by reference.
−Removed: Specimen Common Stock Certificate, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 24, 2018 and incorporated herein by reference.
−Removed: Certificate of Amendment to Tonix Pharmaceuticals Holding Corp.’s Articles of Incorporation, as amended, filed with the Secretary of State of the State of Nevada on May 3, 2019.
−Removed: Specimen Common Stock Certificate of the Registrant, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on May 24, 2018 and incorporated herein by reference.
−Removed: Description of Registrant’s Securities, filed as an exhibit to the Annual Report on Form 10-K, filed with the Commission on March 14, 2022 and incorporated herein by reference.
+Added: and Tonix Pharmaceuticals
+Added: Holding Corp., effective October 11, 2011, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on October
+Added: 17, 2011 and incorporated herein by reference.
+Added: Third Amended and Restated Bylaws, filed as an exhibit to the Current
+Added: Report on Form 8-K, filed with the Commission on June 3, 2016 and incorporated herein by reference.
+Added: Certificate of Change of Tonix Pharmaceuticals Holding Corp., dated
+Added: March 13, 2017 and effective March 17, 2017, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on
+Added: March 16, 2017 and incorporated herein by reference.
+Added: Certificate of Amendment to Articles of Incorporation, effective June
+Added: 16, 2017, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 16, 2017 and incorporated herein
+Added: by reference.
+Added: Specimen Common Stock Certificate, filed as an exhibit to the Current
+Added: Report on Form 8-K, filed with the Commission on May 24, 2018 and incorporated herein by reference.
+Added: Certificate of Amendment to Tonix Pharmaceuticals Holding Corp.’s
+Added: Articles of Incorporation, as amended, filed with the Secretary of State of the State of Nevada on May 3, 2019.
+Added: Form of Certificate of Designation of Series A Convertible Redeemable Preferred Stock, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 22, 2022 and incorporated herein by reference.
+Added: Form of Certificate of Designation of Series B Convertible Redeemable Preferred Stock, filed as an exhibit to the Current Report on Form 8-K, filed with the Commission on June 22, 2022 and incorporated herein by reference.
+Added: Specimen Common Stock Certificate of the Registrant, filed as an exhibit
+Added: to the Current Report on Form 8-K, filed with the Commission on May 24, 2018 and incorporated herein by reference.
+Added: Description of Registrant’s Securities, filed as an exhibit to the Annual Report on Form
+Added: 10-K, filed with the Commission on March 14, 2022 and incorporated herein by reference.
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
7 unchanged sentences
XBRL Taxonomy Presentation Linkbase Document
−Removed: Cover Page Interactive Data File (formatted as Inline XBRL and contained
−Removed: in Exhibits 101)
+Added: Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
Pursuant to the requirements
2 unchanged sentences
TONIX PHARMACEUTICALS HOLDING CORP.
+Added: August 8, 2022
/s/ SETH LEDERMAN
1 unchanged sentence
Chief Executive Officer (Principal Executive Officer)
+Added: August 8, 2022
/s/ BRADLEY SAENGER
Bradley Saenger
−Removed: Chief Financial Officer (Principal Financial Officer
−Removed: and Principal Accounting Officer)
+Added: Chief Financial Officer (Principal Financial Officer and
+Added: Principal Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.